Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $107,750 | 52 | 60.4% |
| Travel and Lodging | $41,701 | 36 | 23.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,454 | 4 | 14.3% |
| Food and Beverage | $3,491 | 52 | 2.0% |
| Education | $93.24 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $118,612 | 98 | $0 (2024) |
| ModernaTX, Inc. | $30,000 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $9,567 | 16 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $8,800 | 4 | $0 (2023) |
| Shire North American Group Inc | $7,381 | 11 | $0 (2019) |
| SANOFI US SERVICES INC. | $2,000 | 4 | $0 (2020) |
| BIOVERATIV THERAPEUTICS INC. | $1,890 | 1 | $0 (2020) |
| BioMarin Pharmaceutical Inc. | $240.00 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43,249 | 17 | ModernaTX, Inc. ($28,800) |
| 2023 | $13,556 | 16 | GENZYME CORPORATION ($9,156) |
| 2022 | $2,400 | 4 | SANOFI-AVENTIS U.S. LLC ($2,400) |
| 2021 | $11,072 | 9 | GENZYME CORPORATION ($5,905) |
| 2020 | $9,790 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($4,800) |
| 2019 | $12,731 | 7 | Shire North American Group Inc ($6,431) |
| 2018 | $41,732 | 32 | GENZYME CORPORATION ($40,019) |
| 2017 | $43,960 | 54 | GENZYME CORPORATION ($43,682) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $26,000.00 | General |
| 09/19/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 09/19/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 09/19/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 09/19/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 09/19/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 09/19/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 06/15/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $8,960.00 | General |
| 06/15/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $444.93 | General |
| 06/15/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $339.94 | General |
| 06/15/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $215.46 | General |
| 06/15/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $128.70 | General |
| 06/15/2024 | GENZYME CORPORATION | — | Food and Beverage | Cash or cash equivalent | $34.71 | General |
| 06/15/2024 | GENZYME CORPORATION | — | Travel and Lodging | Cash or cash equivalent | $18.25 | General |
| 05/20/2024 | GENZYME CORPORATION | CEREZYME (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $500.00 | General |
| Category: Genetic Disease | ||||||
| 02/05/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $95.15 | General |
| 01/12/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $3,712.00 | General |
| 12/05/2023 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 12/05/2023 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 12/05/2023 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 09/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 06/17/2023 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $6,818.00 | General |
| 06/17/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $1,106.71 | General |
| 06/17/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $440.71 | General |
| 06/17/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $346.70 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 11 | $186.00 | $92.40 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $186.00 | $92.40 | 49.7% |
About Dr. Thomas Burrow, MD
Dr. Thomas Burrow, MD is a Clinical Genetics (M.D.) healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699983155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Burrow, MD has received a total of $178,490 in payments from pharmaceutical and medical device companies, with $43,249 received in 2024. These payments were reported across 147 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($107,750).
As a Medicare-enrolled provider, Burrow has provided services to 11 Medicare beneficiaries, totaling 11 services with total Medicare billing of $92.40. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Clinical Genetics (M.D.)
- Other Specialties Clinical Genetics (M.D.)
- Location Little Rock, AR
- Active Since 05/18/2007
- Last Updated 12/15/2016
- Taxonomy Code 207SG0201X
- Entity Type Individual
- NPI Number 1699983155
Products in Payments
- CERDELGA (Drug) $74,353
- CEREZYME (Drug) $15,696
- NO PRODUCT DISCUSSED (Drug) $12,525
- CEREZYME (Biological) $2,390
- DISEASE STATE (Drug) $2,184
- LUMIZYME (Biological) $1,745
- Kuvan (Drug) $140.98
- GAUCHER-DISEASE (Drug) $70.21
- BMN 190 (Biological) $49.02
- ELAPRASE (Biological) $37.65
- VPRIV (Biological) $5.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.